ARMC3
gene geneOn this page
Also known as FLJ32827CT81VAC8
Summary
ARMC3 (armadillo repeat containing 3, HGNC:30964) is a protein-coding gene on chromosome 10p12.2, encoding Armadillo repeat-containing protein 3 (Q5W041). Essential for male fertility and sperm motility.
Armadillo/beta-catenin (CTNNB1; MIM 116806)-like (ARM) domains are imperfect 45-amino acid repeats involved in protein-protein interactions. ARM domain-containing proteins, such as ARMC3, function in signal transduction, development, cell adhesion and mobility, and tumor initiation and metastasis (Li et al., 2006 [PubMed 16915934]).
Source: NCBI Gene 219681 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 140 total
- MANE Select transcript:
NM_173081
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30964 |
| Approved symbol | ARMC3 |
| Name | armadillo repeat containing 3 |
| Location | 10p12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32827, CT81, VAC8 |
| Ensembl gene | ENSG00000165309 |
| Ensembl biotype | protein_coding |
| OMIM | 611226 |
| Entrez | 219681 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 6 protein_coding_CDS_not_defined, 5 protein_coding, 2 retained_intron
ENST00000298032, ENST00000376528, ENST00000409049, ENST00000409983, ENST00000447081, ENST00000464017, ENST00000465729, ENST00000468003, ENST00000473919, ENST00000483596, ENST00000484642, ENST00000491803, ENST00000496741
RefSeq mRNA: 4 — MANE Select: NM_173081
NM_001282745, NM_001282746, NM_001282747, NM_173081
CCDS: CCDS60499, CCDS60500, CCDS7142, CCDS73073
Canonical transcript exons
ENST00000298032 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001092034 | 23032861 | 23033023 |
| ENSE00001092036 | 23030596 | 23030796 |
| ENSE00001092044 | 23001919 | 23002055 |
| ENSE00001092048 | 23003246 | 23003414 |
| ENSE00001092049 | 23008815 | 23008931 |
| ENSE00001092050 | 22981595 | 22981700 |
| ENSE00001092055 | 22961884 | 22962078 |
| ENSE00001092056 | 22998148 | 22998397 |
| ENSE00001092058 | 23006884 | 23006981 |
| ENSE00002310134 | 23037270 | 23038523 |
| ENSE00003458922 | 22981340 | 22981492 |
| ENSE00003531319 | 23008276 | 23008374 |
| ENSE00003534556 | 22946144 | 22946261 |
| ENSE00003570742 | 22959399 | 22959574 |
| ENSE00003579653 | 22968306 | 22968489 |
| ENSE00003650655 | 22931996 | 22932044 |
| ENSE00003655388 | 22959070 | 22959138 |
| ENSE00003689696 | 22955807 | 22955932 |
| ENSE00003843373 | 22928053 | 22928106 |
Expression profiles
Bgee: expression breadth ubiquitous, 149 present calls, max score 98.44.
FANTOM5 (CAGE): breadth broad, TPM avg 1.1659 / max 111.6242, expressed in 297 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 104266 | 1.0733 | 259 |
| 104267 | 0.0600 | 26 |
| 104265 | 0.0327 | 14 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 98.44 | gold quality |
| bronchial epithelial cell | CL:0002328 | 97.39 | gold quality |
| sperm | CL:0000019 | 96.42 | gold quality |
| bronchus | UBERON:0002185 | 95.68 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.75 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 89.41 | gold quality |
| left testis | UBERON:0004533 | 88.20 | gold quality |
| right testis | UBERON:0004534 | 87.96 | gold quality |
| oviduct epithelium | UBERON:0004804 | 86.96 | gold quality |
| testis | UBERON:0000473 | 85.90 | gold quality |
| fallopian tube | UBERON:0003889 | 85.71 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.81 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 82.15 | gold quality |
| nasopharynx | UBERON:0001728 | 82.14 | gold quality |
| monocyte | CL:0000576 | 80.23 | gold quality |
| leukocyte | CL:0000738 | 79.35 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 78.34 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.19 | gold quality |
| right lung | UBERON:0002167 | 74.07 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 73.32 | gold quality |
| caudate nucleus | UBERON:0001873 | 72.49 | gold quality |
| nucleus accumbens | UBERON:0001882 | 71.45 | gold quality |
| left uterine tube | UBERON:0001303 | 70.12 | gold quality |
| hypothalamus | UBERON:0001898 | 70.11 | gold quality |
| pancreatic ductal cell | CL:0002079 | 69.72 | silver quality |
| adenohypophysis | UBERON:0002196 | 69.63 | gold quality |
| body of pancreas | UBERON:0001150 | 67.73 | gold quality |
| corpus callosum | UBERON:0002336 | 67.60 | gold quality |
| endometrium | UBERON:0001295 | 67.16 | gold quality |
| pituitary gland | UBERON:0000007 | 67.05 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 62.22 |
| E-MTAB-10287 | yes | 25.52 |
| E-ANND-3 | yes | 11.38 |
| E-MTAB-9388 | yes | 7.46 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
71 targeting ARMC3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-8084 | 99.73 | 69.57 | 1760 |
| HSA-MIR-12129 | 99.72 | 67.45 | 1311 |
| HSA-MIR-4804-3P | 99.65 | 67.78 | 866 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-6757-3P | 99.63 | 66.88 | 1089 |
| HSA-MIR-762 | 99.58 | 66.61 | 1994 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-4761-5P | 99.51 | 66.69 | 804 |
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
Literature-anchored findings (GeneRIF, showing 4)
- KU-CT-1 is a new cancer testis antigen that is expressed in pancreatic, lung, and endometrial cancers (PMID:16397042)
- ARMC3_v2 was detected in human skeletal muscle, liver, spleen and thymus; in contrast, ARMC3_v1 in skeletal muscle, lung, prostate and testis (PMID:16915934)
- The Expansion of the Spectrum in Stuttering Disorders to a Novel ARMC Gene Family (ARMC3). (PMID:36553564)
- A homozygous ARMC3 splicing variant causes asthenozoospermia and flagellar disorganization in a consanguineous family. (PMID:39221575)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | armc3 | ENSDARG00000074708 |
| mus_musculus | Armc3 | ENSMUSG00000037683 |
| rattus_norvegicus | Armc3 | ENSRNOG00000016716 |
Paralogs (4): ANKAR (ENSG00000151687), CTNNB1 (ENSG00000168036), ODAD2 (ENSG00000169126), JUP (ENSG00000173801)
Protein
Protein identifiers
Armadillo repeat-containing protein 3 — Q5W041 (reviewed: Q5W041)
Alternative names: Beta-catenin-like protein, Cancer/testis antigen 81, KU-CT-1
All UniProt accessions (3): B4DXS3, C9JC46, Q5W041
UniProt curated annotations — full annotation on UniProt →
Function. Essential for male fertility and sperm motility. During spermatogenesis, promotes the autophagic degradation of excessive ribosomes, providing energy resources for mitochondria and thus ensuring sperm flagellar motility.
Subunit / interactions. Homodimer. Interacts with PIK3C3, PIK3R4 and BECN1. Interacts (via ARM domains) with ATG14. Interacts with MYCBPAP.
Tissue specificity. Expressed in skeletal muscle, brain, lung, kidney, prostate and testis. Mainly expressed in skeletal muscle, liver, spleen and thymus. Expressed only in the testis among normal tissues but is expressed frequently in various cancer tissues and, particularly, in pancreatic, lung and endometrial cancers.
Post-translational modifications. Palmitoylation is important for its function in autophagy.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5W041-2 | 1, ARMC3_Nu1, KU-CT-1L | yes |
| Q5W041-3 | 3, ARMC3_Nu2 | |
| Q5W041-4 | 4 | |
| Q5W041-5 | 5, KU-CT-1 |
RefSeq proteins (4): NP_001269674, NP_001269675, NP_001269676, NP_775104* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000225 | Armadillo | Repeat |
| IPR011989 | ARM-like | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR052441 | Armadillo-Ser/Thr_Kinase | Family |
| IPR055164 | EDR1/CTR1/ARMC3-like_pept-like | Domain |
| IPR055445 | ARM_ARMC5 | Domain |
Pfam: PF00514, PF14381, PF24768
UniProt features (29 total): repeat 12, splice variant 5, sequence variant 4, compositionally biased region 3, lipid moiety-binding region 2, chain 1, region of interest 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5W041-F1 | 84.81 | 0.74 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 507, 518
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 114 (showing top):
GOBP_MALE_GAMETE_GENERATION, EFC_Q6, GOBP_MACROAUTOPHAGY, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, CYTAGCAAY_UNKNOWN, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, chr10p12, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CHEN_METABOLIC_SYNDROM_NETWORK, MIKKELSEN_ES_ICP_WITH_H3K4ME3, NOUSHMEHR_GBM_SILENCED_BY_METHYLATION
GO Biological Process (6): spermatid development (GO:0007286), flagellated sperm motility (GO:0030317), ribophagy (GO:0034517), autophagy (GO:0006914), spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): extracellular exosome (GO:0070062)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| germ cell development | 1 |
| spermatid differentiation | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| macroautophagy | 1 |
| catabolic process | 1 |
| transmembrane transport | 1 |
| process utilizing autophagic mechanism | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| binding | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
2301 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ARMC3 | TMEM95 | Q3KNT9 | 665 |
| ARMC3 | CFAP119 | A1A4V9 | 617 |
| ARMC3 | CFAP96 | A7E2U8 | 545 |
| ARMC3 | TEKT1 | Q969V4 | 545 |
| ARMC3 | CFAP184 | Q2M329 | 540 |
| ARMC3 | CFAP90 | A4QMS7 | 524 |
| ARMC3 | IQUB | Q8NA54 | 507 |
| ARMC3 | FOXJ1 | Q92949 | 505 |
| ARMC3 | CLXN | Q9HAE3 | 497 |
| ARMC3 | PIERCE1 | Q5BN46 | 493 |
| ARMC3 | AKAP3 | O75969 | 490 |
| ARMC3 | DRC10 | Q96DY2 | 483 |
| ARMC3 | VWA3A | A6NCI4 | 476 |
| ARMC3 | FAM81B | Q96LP2 | 469 |
| ARMC3 | CIMAP3 | Q8TCI5 | 459 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARMC3 | HSD17B12 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ARMC3 | CRACR2A | psi-mi:“MI:0915”(physical association) | 0.400 |
| ARMC3 | NMT2 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (6): ARMC3 (Proximity Label-MS), CRACR2A (Proximity Label-MS), ARMC3 (Affinity Capture-RNA), NMT2 (Affinity Capture-MS), ARMC3 (Cross-Linking-MS (XL-MS)), ARMC3 (Affinity Capture-MS)
ESM2 similar proteins: A2AU72, B0F9L4, E9Q912, F1QWA8, O35099, O46563, O75165, O75602, O93614, P0C6R2, P39968, P42345, P42346, P52306, Q04173, Q1RMS6, Q21029, Q5EFZ4, Q5PPZ9, Q5W041, Q5ZL91, Q66L58, Q68FK4, Q6BTZ4, Q6C5Y8, Q6CX49, Q6DD21, Q6FJV1, Q6NUP7, Q6PIY5, Q757R0, Q7YRF1, Q80TR8, Q80W92, Q80WQ2, Q84ZC0, Q8BVE3, Q8BW49, Q8C0Y0, Q8NFP9
Diamond homologs: A2AU72, Q05609, Q5W041, Q9C9U5, Q9FPR3, O22161, Q9M224
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
140 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 121 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3771 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:22946142:A:AG | acceptor_gain | 1.0000 |
| 10:22946143:G:GG | acceptor_gain | 1.0000 |
| 10:22955798:T:TA | acceptor_gain | 1.0000 |
| 10:22959397:A:AG | acceptor_gain | 1.0000 |
| 10:22959398:G:GG | acceptor_gain | 1.0000 |
| 10:22965236:GT:G | donor_gain | 1.0000 |
| 10:22981327:T:A | acceptor_gain | 1.0000 |
| 10:22981328:G:A | acceptor_gain | 1.0000 |
| 10:22981592:TAG:T | acceptor_loss | 1.0000 |
| 10:22981593:A:C | acceptor_loss | 1.0000 |
| 10:22981593:AG:A | acceptor_gain | 1.0000 |
| 10:22981593:AGG:A | acceptor_gain | 1.0000 |
| 10:22981594:GG:G | acceptor_gain | 1.0000 |
| 10:22981594:GGG:G | acceptor_gain | 1.0000 |
| 10:22981696:GCAAA:G | donor_gain | 1.0000 |
| 10:22981701:G:GG | donor_gain | 1.0000 |
| 10:22998138:A:AG | acceptor_gain | 1.0000 |
| 10:22998139:T:G | acceptor_gain | 1.0000 |
| 10:22998142:A:AG | acceptor_gain | 1.0000 |
| 10:22998143:C:G | acceptor_gain | 1.0000 |
| 10:22998146:A:AG | acceptor_gain | 1.0000 |
| 10:22998146:AGC:A | acceptor_gain | 1.0000 |
| 10:22998147:G:GA | acceptor_gain | 1.0000 |
| 10:22998147:GC:G | acceptor_gain | 1.0000 |
| 10:22998147:GCG:G | acceptor_gain | 1.0000 |
| 10:22998147:GCGC:G | acceptor_gain | 1.0000 |
| 10:22998147:GCGCT:G | acceptor_gain | 1.0000 |
| 10:22998395:GAG:G | donor_gain | 1.0000 |
| 10:22998398:G:GG | donor_gain | 1.0000 |
| 10:22998398:G:T | donor_loss | 1.0000 |
AlphaMissense
5747 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:23033007:G:C | R798P | 0.998 |
| 10:23030790:T:C | L747P | 0.996 |
| 10:23033023:G:C | K803N | 0.996 |
| 10:23033023:G:T | K803N | 0.996 |
| 10:23037276:G:C | A806P | 0.994 |
| 10:23037304:T:C | L815P | 0.994 |
| 10:22959425:A:C | S130R | 0.993 |
| 10:22959427:T:A | S130R | 0.993 |
| 10:22959427:T:G | S130R | 0.993 |
| 10:23032991:G:A | G793R | 0.992 |
| 10:23032991:G:C | G793R | 0.992 |
| 10:23033006:C:G | R798G | 0.992 |
| 10:23033016:T:C | L801P | 0.992 |
| 10:23037274:T:C | L805P | 0.992 |
| 10:23037277:C:A | A806D | 0.992 |
| 10:23037310:G:C | R817P | 0.992 |
| 10:23037330:T:A | W824R | 0.992 |
| 10:23037330:T:C | W824R | 0.992 |
| 10:22946196:T:C | L34P | 0.991 |
| 10:23002000:G:C | A503P | 0.991 |
| 10:23003368:T:C | L562S | 0.991 |
| 10:23003397:T:C | F572L | 0.991 |
| 10:23003399:C:A | F572L | 0.991 |
| 10:23003399:C:G | F572L | 0.991 |
| 10:23030792:G:C | A748P | 0.991 |
| 10:22955828:T:C | L63P | 0.990 |
| 10:23032868:G:C | A752P | 0.990 |
| 10:23033010:C:A | A799D | 0.990 |
| 10:23037335:T:A | N825K | 0.990 |
| 10:23037335:T:G | N825K | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000005073 (10:23009944 T>C), RS1000019192 (10:22994326 C>T), RS1000096909 (10:22970985 C>A), RS1000149536 (10:22971269 G>A,C), RS1000194476 (10:22934547 G>A), RS1000195988 (10:22941605 T>C), RS1000225963 (10:22958902 T>C), RS1000244366 (10:22997261 A>T), RS1000299567 (10:22944673 G>A), RS1000337045 (10:22984494 T>C), RS1000341075 (10:22938533 G>C), RS1000392186 (10:22977393 C>T), RS1000408319 (10:22997358 C>T), RS1000449785 (10:22964068 G>A), RS1000454559 (10:22965422 A>G)
Disease associations
OMIM: gene MIM:611226 | disease phenotypes: MIM:614668
GenCC curated gene-disease
Mondo (1): stuttering, familial persistent, 4 (MONDO:0013844)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002875_43 | Diisocyanate-induced asthma | 2.000000e-06 |
| GCST004361_14 | Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer | 5.000000e-06 |
| GCST004867_14 | Systemic lupus erythematosus | 2.000000e-07 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006995 | response to diisocyanate |
| EFO:0007970 | estrone measurement |
| EFO:0007972 | androstenedione measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| aristolochic acid I | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | increases expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Estradiol | increases expression | 1 |
| Malathion | decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Particulate Matter | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): stuttering, familial persistent, 4